Lipocine Investor Room http://ir.lipocine.com/ Lipocine Announces Financial and Operational Results for the Three and Nine Months Ended September 30, 2018 http://ir.lipocine.com/2018-11-07-Lipocine-Announces-Financial-and-Operational-Results-for-the-Three-and-Nine-Months-Ended-September-30-2018 Wed, 07 Nov 2018 08:00:00 -0500 http://ir.lipocine.com/2018-11-07-Lipocine-Announces-Financial-and-Operational-Results-for-the-Three-and-Nine-Months-Ended-September-30-2018 Lipocine Announces Completion of Enrollment in LPCN 1144 Liver Imaging Study in Subjects At-Risk for NASH http://ir.lipocine.com/2018-11-05-Lipocine-Announces-Completion-of-Enrollment-in-LPCN-1144-Liver-Imaging-Study-in-Subjects-At-Risk-for-NASH Mon, 05 Nov 2018 08:00:00 -0500 http://ir.lipocine.com/2018-11-05-Lipocine-Announces-Completion-of-Enrollment-in-LPCN-1144-Liver-Imaging-Study-in-Subjects-At-Risk-for-NASH Lipocine Announces Completion of Enrollment in Ambulatory Blood Pressure Study for TLANDO™ http://ir.lipocine.com/2018-11-01-Lipocine-Announces-Completion-of-Enrollment-in-Ambulatory-Blood-Pressure-Study-for-TLANDO-TM Thu, 01 Nov 2018 16:00:00 -0400 http://ir.lipocine.com/2018-11-01-Lipocine-Announces-Completion-of-Enrollment-in-Ambulatory-Blood-Pressure-Study-for-TLANDO-TM Lipocine Announces LPCN 1144 Clinical Trial Results Selected for Late-Breaker Presentation at The Liver Meeting® 2018 http://ir.lipocine.com/2018-10-11-Lipocine-Announces-LPCN-1144-Clinical-Trial-Results-Selected-for-Late-Breaker-Presentation-at-The-Liver-Meeting-R-2018 Thu, 11 Oct 2018 08:00:00 -0400 http://ir.lipocine.com/2018-10-11-Lipocine-Announces-LPCN-1144-Clinical-Trial-Results-Selected-for-Late-Breaker-Presentation-at-The-Liver-Meeting-R-2018 Lipocine to Present at the Ladenburg Thalmann 2018 Healthcare Conference http://ir.lipocine.com/2018-09-25-Lipocine-to-Present-at-the-Ladenburg-Thalmann-2018-Healthcare-Conference Tue, 25 Sep 2018 08:00:00 -0400 http://ir.lipocine.com/2018-09-25-Lipocine-to-Present-at-the-Ladenburg-Thalmann-2018-Healthcare-Conference